Literature DB >> 19966534

Low-calorie diet-induced reduction in serum HDL cholesterol is ameliorated in obese women with the -3826 G allele in the uncoupling protein-1 gene.

Taku Hamada1, Kazuhiko Kotani, Narumi Nagai, Kokoro Tsuzaki, Yukiyo Matsuoka, Yoshiko Sano, Mami Fujibayashi, Natsuki Kiyohara, Seitaro Tanaka, Makiko Yoshimura, Kahori Egawa, Yoshinori Kitagawa, Yoshinobu Kiso, Toshio Moritani, Naoki Sakane.   

Abstract

The uncoupling protein-1 (UCP1) gene is of major importance for regulation of body weight and lipid/lipoprotein metabolism. Our cross-sectional study has shown that subjects with the G/G genotype of the -3826 A/G polymorphism in the UCP-1 gene have higher levels of serum high-density lipoprotein cholesterol (HDL-C) than those with other genotypes. Low circulating HDL-C level has been regarded as a major atherosclerotic risk factor. We therefore investigated whether the -3826 A/G polymorphism affects the obesity- and lipid-related parameters during a low-calorie diet (LCD) intervention. In 32 obese women (49.9 +/- 8.4 years of age), anthropometric, physiological and biochemical characteristics were measured before and after a 2-month LCD treatment, which restricted each subject to the same energy intakes, such as 5,120 kJ/day. The -3826 A/G polymorphism was detected using a PCR-restriction fragment-length polymorphism method. There were 6 subjects with the A/A genotype, 15 with the A/G genotype and 11 with the G/G genotype. The LCD intervention decreased weight (P < 0.001) and serum HDL-C levels (P < 0.05) in all subjects. There was no difference in the levels of change in weight, nutrient intake, physiological measurements in energy expenditure, and fat oxidation between subjects with and without the G allele. In contrast, the degree of the reduction in the HDL-C levels was significantly smaller in subjects with the G allele than those without the G allele. These results suggest that the G allele at -3826 in the UCP1 gene may ameliorate the reduction in serum HDL-C levels in obese women during LCD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19966534     DOI: 10.1620/tjem.219.337

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  4 in total

Review 1.  Quantile-Dependent Expressivity and Gene-Lifestyle Interactions Involving High-Density Lipoprotein Cholesterol.

Authors:  Paul T Williams
Journal:  Lifestyle Genom       Date:  2020-12-09

2.  Prevalence of uncoupling protein one genetic polymorphisms and their relationship with cardiovascular and metabolic health.

Authors:  Petros C Dinas; Eleni Nintou; Maria Vliora; Anna E Pravednikova; Paraskevi Sakellariou; Agata Witkowicz; Zaur M Kachaev; Victor V Kerchev; Svetlana N Larina; James Cotton; Anna Kowalska; Paraskevi Gkiata; Alexandra Bargiota; Zaruhi A Khachatryan; Anahit A Hovhannisyan; Mariya A Antonosyan; Sona Margaryan; Anna Partyka; Pawel Bogdanski; Monika Szulinska; Matylda Kregielska-Narozna; Rafał Czepczyński; Marek Ruchała; Anna Tomkiewicz; Levon Yepiskoposyan; Lidia Karabon; Yulii Shidlovskii; George S Metsios; Andreas D Flouris
Journal:  PLoS One       Date:  2022-04-28       Impact factor: 3.752

3.  Nutritional Strategies for the Individualized Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) Based on the Nutrient-Induced Insulin Output Ratio (NIOR).

Authors:  Ewa Stachowska; Karina Ryterska; Dominika Maciejewska; Marcin Banaszczak; Piotr Milkiewicz; Małgorzata Milkiewicz; Izabela Gutowska; Piotr Ossowski; Małgorzata Kaczorowska; Dominika Jamioł-Milc; Anna Sabinicz; Małgorzata Napierała; Lidia Wądołowska; Joanna Raszeja-Wyszomirska
Journal:  Int J Mol Sci       Date:  2016-07-22       Impact factor: 5.923

4.  Association of Uncoupling Protein 1 (UCP1) gene polymorphism with obesity: a case-control study.

Authors:  Shahanas Chathoth; Mona H Ismail; Chittibabu Vatte; Cyril Cyrus; Zhara Al Ali; Khandaker Ahtesham Ahmed; Sadananda Acharya; Aisha Mohammed Al Barqi; Amein Al Ali
Journal:  BMC Med Genet       Date:  2018-11-20       Impact factor: 2.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.